The U.S. Department of Transportation published a final rule April 23 that makes technical corrections to regulations governing drug testing for safety-sensitive employees to ensure consistency with recent amendments made to DOT’s “Procedures for Transportation Workplace Drug and Alcohol Testing Programs,” which recently added requirements for testing for oxycodone, oxymorphone, hydrocodone and hydromorphone.
According to the release from DOT, the new changes to the department’s regulations make it necessary to refer to these substances, as well as morphine, 6-acetylmorphine and codeine by the term “opioids” rather than “opiates.”
This final rule amends the term in the FAA, FTA and PHMSA regulations to ensure that all DOT drug testing rules are consistent with one another and the mandatory guidelines for the testing program.
Click here to read more about this final rule.
Related News
- Report Blocked Crossings with New FRA Digital Tool
- LAST CALL: Submit Your Photos for 2026 Calendar Today!
- Heroic Act on the Rails: SMART-TD Brother Burned while Saving Crewmate
- Unions Join Together to Fix Overtime Tax Loophole for Transportation Workers
- Help Amtrak Conductor, Local 166 Member Get Back to Work
- CSX Trainee Death Exposes Glaring Safety Gaps
- Fewer Eyes Mean More Derailments
- Santa Monica Local Wins Cost of Living Increases
- Senate Hearing Indicates Trouble for Public Transportation
- REMINDER: Registration Open for Anaheim Regional Training Seminar